<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

 Longevity Leaders Logo WhiteRNA Leaders USA Congress Logo White


SCIENTIFIC, CLINICAL AND COMMERCIAL DEVELOPMENT OF RNA THERAPEUTICS AND VACCINES


October 18-19, 2022

The Colonnade Hotel, 120 Huntington Ave, Boston, MA, USA

DOWNLOAD BROCHURE

TICKET OPTIONS

Follow us on linkedin
RNA Leaders
#rnaleaders

Created by    LSX

A new paradigm for disease prevention



RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic.

But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful.

Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging.

With that in mind, we can’t wait to bring the community together, face-to-face, for the RNA Leaders USA Congress.

RNA Leaders World Congress

 

1-2-1 Partnering


Hosting qualified partnering meetings at RNA Leaders

Transform your partnering experience. With our app-based partnering system, you can schedule, move and confirm meetings ‘on the fly’.

Find new strategic partnerships, search for companies with similar interests or connect with potential clients face-to-face.

LEARN MORE

RNA EU 2022 Networking 4

RNA Leaders speakers



Brett Monia, CEO, Ionis Pharmaceuticals

Brett Monia

CEO
Ionis Pharmaceuticals
Frank de Rosa, Chief Technology Officer & Global Head of Research, mRNA Center of Excellence, Sanofi

Frank de Rosa

Chief Technology Officer & Global Head of Research, mRNA Center of Excellence
Sanofi
Lucio Iannone, VP of Venture Investments Health, Leaps at Bayer

Lucio Iannone

VP of Venture Investments Health
Leaps at Bayer
Lovisa Afzelius, CEO, Alltrna, & Origination Partner, Flagship Pioneering

Lovisa Afzelius

CEO, Alltrna
Origination Partner, Flagship Pioneering
Peter Smith, CEO, Remix Therapeutics

Peter Smith

CEO
Remix Therapeutics
Matthew Disney, Chair, Scripps Research

Matt Disney

Professor, Department of Chemistry
Scripps Research
Dietrich Stephan

Dietrich Stephan

Chairman and Chief Executive Officer
NeuBase Therapeutics
Karen Chapman, CSO, Eclipsebio

Karen Chapman

CSO
Eclipsebio
Samuel Wickline, Chief Scientific Officer, Altamira Therapeutics, Inc.

Samuel Wickline

CSO
Altamira Therapeutics
Hans-Peter Vornlocher, Managing Director, Research, LGC Axolabs

Hans-Peter Vornlocher

Managing Director, Research
LGC Axolabs
Katarina Stenklo, Enterprise Solutions Commercial Activation Leader, Cytiva

Katarina Stenklo

Enterprise Solutions Commercial Activation Leader
Cytiva
Jeremy Little, Director, Custom Oligonucleotides, Chemgenes

Jeremy Little

Director, Custom Oligonucleotides
Chemgenes

DOWNLOAD BROCHURE


Venue

Centrally located and exquisitely appointed in the iconic Back Bay neighborhood, The Colonnade Hotel in Boston MA is a contemporary luxury hotel.

Programme

Keynote panels, keynote presentations, panel sessions and plenty of networking time built in. See the program of RNA Leaders. 

Partnering

Our state-of-the-art app-based 1-2-1 partnering system allows you to schedule, move and confirm meetings ‘on the fly’. 


What Our Attendees Say


Platinum partners


 

Chemgenes logo

 

Precision Nanosystems

 

Gold partners


 

4basebio logo

Axolabs 300x

BiOrchestra Logo

Cytiva-1

Micropore Technologies Logo

Wuxi AppTec

 

Silver partners


 

Altamira Therapeutics logo

Eclipse Bioinnovations

 

Remix Therapeutics 300x

 

Sisaf Logo

Bronze partners


 

Aptamer group logo

Catalent

Cend Therapeutics Logo

Development Centre for Biotechnology logo

eTheRNA Logo

Exopharm Logo-1

GenScript logo

Novartis Global Biotech Corporations

Northern RNA logo

PolyPeptide Group 300x

purehoney technologies logo

“We still have work to do, but the future is bright for RNA therapies.”
Lorna Harries, CSO, Senisca

What will you learn?



  • How the RNA field has accelerated in the past two years, including major scientific and clinical developments
  • New advancements in systemic and topical delivery platforms and their applications
  • How computational biology is advancing RNA drug discovery including new tools for target, mechanism and molecule discovery
  • Latest pre-clinical updates spanning mRNA, RNAi, antisense and targeting RNA with small molecules
  • Application of gene therapy and RNA editing approaches

Become a partner



Do you offer products or services to support RNA drug development? The pharma and biotech executives attending RNA Leaders World Congress want to meet you! They are looking for:

RNA icone 1

RNA icone 2

RNA icone 3

RNA icone 8

RNA icone 7

RNA icone 4

RNA icone 9

RNA icone 6

RNA icone 5

DOWNLOAD BROCHURE
Female Founders

Networking, Dialogue And Mentorship For Women In Health And Life Sciences
Members save 25% off all LSX events.

FIND OUT MORE

Subscribe to hear speaker announcements, ticket offers and more